Pneumonitis: a serious adverse effect of PD-L1 inhibitors including pembrolizumab

Research output: Contribution to journalArticle (Academic Journal)peer-review

Original languageEnglish
JournalBMJ Case Reports
Publication statusPublished - May 2018

Cite this